German researchers have transformed blood cells from an 80-year-old into neural stem cells with a molecular age under 20 — effectively reversing more than 60 years of cellular aging. The team at the University of Bonn bypassed a key step in traditional reprogramming, allowing them to track the gradual rejuvenation process over 100+ days. The findings could open new doors for understanding and treating age-related diseases like Alzheimer's.
Researchers at the University of Bonn have reprogrammed blood cells from an 80-year-old into neural stem cells with a molecular age of less than 20 years — reversing more than six decades of cellular aging in the lab. The process relies on a cocktail of transcription factors that rewire which genetic instructions a cell follows, effectively resetting the cell's epigenetic clock and giving it a dramatically younger biological profile.
What sets this study apart is how the rejuvenation unfolded. Earlier methods required a two-step process — converting cells into pluripotent stem cells first, then guiding them toward a neural fate — causing rejuvenation to happen rapidly and making it difficult to study. The Bonn team skipped the pluripotent stage entirely, converting blood cells directly into neural stem cells. This produced a slow, trackable transformation over more than 100 days, giving scientists an unprecedented window into the mechanics of cellular age reversal.
By the Numbers:
Why it matters: Age is the single biggest risk factor for neurodegenerative diseases like Alzheimer's. This new model gives researchers a slow-motion view of cellular rejuvenation, making it possible to identify which factors accelerate or slow the process — and potentially uncover new therapeutic targets for age-related brain diseases.
